This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Non Small Cell Lung Cancer
and you are
over 20
years old
This is a medium phase trial determining
the safety and dosage of the new treatment, as well as its efficacy.
Show me locations

The purpose

The main objective of this study is to evaluate the safety and tolerability of HM61713.

Provided treatments

  • Drug: HM61713

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT01588145. The sponsor of the trial is Hanmi Pharmaceutical Company Limited and it is looking for 273 volunteers for the current phase.
Official trial title:
Phase I/II Study to Assess the Safety, Tolerability, Pharmacokinetics and Anti-tumor Activity of HM61713 in NSCLC Patients With EGFR Mutation